SPONSOR
Shanghai Pharmaceuticals Holding Co., Ltd
Total Trials
3
Recruiting
3
Phases
Phase 1, Phase 2, Phase 2, EARLY_Phase 1
Shanghai Pharmaceuticals Holding Co., Ltd is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Advanced Melanoma, Acute Ischemic Stroke, Inflammatory Bowel Disease.
The trial portfolio spans Phase 1, Phase 2, Phase 2, EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Shanghai Pharmaceuticals Holding Co., Ltd
How many clinical trials has Shanghai Pharmaceuticals Holding Co., Ltd sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Shanghai Pharmaceuticals Holding Co., Ltd, of which 3 are actively recruiting participants. These trials cover conditions including Advanced Melanoma, Acute Ischemic Stroke, Inflammatory Bowel Disease. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Shanghai Pharmaceuticals Holding Co., Ltd research focus on?
Shanghai Pharmaceuticals Holding Co., Ltd clinical trials span Advanced Melanoma, Acute Ischemic Stroke, Inflammatory Bowel Disease. The research pipeline includes Phase 1, Phase 2, Phase 2, EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Shanghai Pharmaceuticals Holding Co., Ltd clinical trial?
To participate in a Shanghai Pharmaceuticals Holding Co., Ltd trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Shanghai Pharmaceuticals Holding Co., Ltd trials with current recruitment status updated daily.
Clinical Trials by Shanghai Pharmaceuticals Holding Co., Ltd
NCT06214156 Phase 1, Phase 2
Recruiting
A Clinical Study of T3011 in Subjects With Advanced Melanoma
Advanced Melanoma
NCT05686642 Phase 2
Recruiting
Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke
Acute Ischemic Stroke
NCT06483373 EARLY_Phase 1
Recruiting
A Clinical Study of SPH7854 Granules in Healthy Subjects.
Inflammatory Bowel Disease
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology